Disclosure of Relationship. Each party (including the respective affiliates) shall have the right upon obtaining prior written consent from the other party, from time to time, to publish, distribute, advertise or otherwise disclose the relationship and the general services created and performed under this Agreement; provided, however, such disclosure shall not identify the amount or nature of fees earned or to be paid hereunder. No disclosure permitted by this Section 9.10 shall include any Mortgagor information.
Disclosure of Relationship. Each Legal Entity acknowledges and agrees that the QI shall have the right to disclose the relationships set forth in this Agreement to any Seller, Buyer or other person and that the QI is, and is acting in the sole capacity as, Exchangor’s Qualified Intermediary.
Disclosure of Relationship. The parties each shall be entitled to disclose that the SAB Member is serving on the SAB and RXi may use the SAB Member’s name and, in doing so may cite the SAB Member’s relationship with the Institute, including in any business plan, press release, advertisement, prospectus or other offering document of RXi or its affiliates, so long as any such usage (a) is limited to reporting factual events or occurrences only, and (b) is made in a manner that could not reasonably constitute a specific endorsement by the Institute or the SAB Member of RXi or of any program, product or service of RXi. However, RXi shall not use the SAB Member’s name or the Institute’s name in any press release, or quote the SAB Member in any RXi materials (including advertisements), or otherwise use the SAB Member’s name or the Institute’s name in a manner not specifically permitted by the preceding sentence, unless in each case RXi obtains in advance the written consent of the Institute, and, in the case of the use of the SAB Member’s name, the SAB Member’s consent as well. The foregoing consents shall not be unreasonably withheld or delayed by the SAB Member. Notwithstanding the foregoing, if, in the opinion of RXi’s counsel, RXi is required by applicable law to use the SAB Member’s name or the Institute’s name in a press release or governmental filing and, under the circumstances, RXi is not reasonably able to obtain the advance written consent of the Institute or the SAB Member, as applicable, to such use, then RXi may proceed without obtaining the advance written consent of the Institute or the SAB Member, as applicable.
Disclosure of Relationship. Section 9.10
Disclosure of Relationship. No printed or other matter in any language (including prospectuses, notices, reports, and promotional material) that mentions Escrow Agent's name or the rights, powers, or duties of Escrow Agent will be issued by the other parties hereto or on such parties' behalf unless Escrow Agent will first have given its specific written consent thereto.
Disclosure of Relationship. The Consultant agrees that it will disclose in a manner consistent with applicable laws, rules and regulations that it is providing the services set forth above in this Agreement and in exchange for Common Stock of the Company. Specifically the Consultant agrees to abide by Section 17(b) of the 1933 Act which provides that it is unlawful for any person: "to publish, give publicity to, or to circulate any notice, circular, or advertisement, newspaper article, letter, investment service, or communication which, though not purporting to offer a security for sale, describes such security for a consideration received or to be received, directly or indirectly, from an issuer, underwriter or dealer, without fully disclosing receipt, whether past or prospective, of such compensation and the amount thereof."
Disclosure of Relationship. The parties each shall be entitled to disclose that the Advisor is serving as a scientific advisor to RXi and RXi may use the Advisor’s name, including in any business plan, press release, advertisement, prospectus or other offering document of RXi or its affiliates, so long as any such usage (a) is limited to reporting factual events or occurrences only, and (b) is made in a manner that could not reasonably constitute a specific endorsement by the Advisor of RXi or of any program, product or service of RXi. However, RXi shall not use the Advisor’s name in any press release, or quote the Advisor in any RXi materials (including advertisements), or otherwise use the Advisor’s name in a manner not specifically permitted by the preceding sentence, unless in each case RXi obtains in advance the Advisor’s consent. The foregoing consents shall not be unreasonably withheld or delayed by the Advisor. Notwithstanding the foregoing, if, in the opinion of RXi’s counsel, RXi is required by applicable law to use the Advisor’s name in a press release or governmental filing and, under the circumstances, RXi is not reasonably able to obtain the advance written consent of the Advisor, as applicable, to such use, then RXi may proceed without obtaining the advance written consent of the Advisor.
Disclosure of Relationship. Notwithstanding Section 6.1, (i) on or after the Effective Date, the Parties shall agree to make publicly known the existence of the cross-licenses granted herein and the dismissal of the pending litigation through an appropriate joint [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. press release and/or individual press releases, which content shall have been pre-approved by the Parties, such approval not to be unreasonably withheld, conditioned or delayed; and (ii) Licensor and the Patent Owners shall be allowed to mention Licensee’s name as licensee of the Licensor Licensed Patent Rights in their brochures and webpages in relation with their technology commercialization efforts and achievements; provided that Licensee’s name as licensor of the A123 Patent Rights is also mentioned and that Licensee shall be allowed to mention Licensor’s name as licensee of the A123 Patent Rights in its brochures and webpages in relation with its technology commercialization efforts and achievements. Licensor and Licensee agree that the press release attached as Schedule 6.4 hereto is hereby approved by both Parties, and that either Party may publicize the contents of such press release without restriction hereunder.
Disclosure of Relationship. The Company may (but is not obligated to) identify the Contractor in its promotional and/or other materials as a consultant, strategist, senior advisor, or such other descriptive title. The Contractor may identify and/or disclose its relationship with the Company in promotional or other materials only upon the Company’s prior written consent and with the Company having had the opportunity to review and approve such promotional or other materials, which approval will not be unreasonably withheld by the Company.
Disclosure of Relationship. The parties each shall be entitled to disclose that Advisor is serving on the Company’s Scientific Advisory Board, including in any filing, prospectus, press release, business plan, advertisement, or other offering document of the Company or its affiliates; provided, that Advisor shall have the opportunity to review and approve press releases relating to announcement of this Agreement and developments in the business of the Company prior to release, with approval of such press releases not to be unreasonably delayed or withheld. Notwithstanding the foregoing, the Company shall not require the approval by Advisor of any governmental filing or press release that in the opinion of the Company’s counsel is required to be made.
